Original Research
Published on 18 Feb 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth
in Cancer Molecular Targets and Therapeutics
- 405 views
Original Research
Published on 18 Feb 2026
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 18 Feb 2026
in Neural Technology
Review
Published on 18 Feb 2026
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 18 Feb 2026
in Pulmonary Medicine
Original Research
Published on 18 Feb 2026
in Cellular Biochemistry
Original Research
Published on 18 Feb 2026
in Nutrition and Food Science Technology
Original Research
Published on 18 Feb 2026
in Family Medicine and Primary Care
Original Research
Published on 18 Feb 2026
in Children and Health
Original Research
Published on 18 Feb 2026
in Molecular Innate Immunity
Original Research
Published on 18 Feb 2026
in Emotion Regulation and Processing
Case Report
Published on 18 Feb 2026
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 18 Feb 2026
in Medical Physics and Imaging
Original Research
Published on 18 Feb 2026
in Behavioral and Evolutionary Ecology
Case Report
Published on 18 Feb 2026
in Psychopharmacology
Case Report
Published on 18 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Feb 2026